Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/accessible diagnostic methods.
A correction to this paper has been published: the notice, 42768843, from Europe PMC.
Overview
and 51 other authors
Tomonari Suzuki14, Koji Yoshimoto15, Daisuke Kuga15, Keishi Horiguchi16, Shigeru Yamaguchi17, Masayuki Kanamori18, Kai Yamasaki19, Kenichi Ishibashi20, Takuya Akai21, Masayoshi Yamaoka22, Ryuji Ishizaki23, Atsufumi Kawamura24, Shigeo Ohba25, Joji Ishida26, Ryo Ando27, Junya Fukai28, Tomoru Miwa29, Masazumi Fujii30, Ai Muroi31, Kuniaki Saito32, Atsuko Harada33, Yasuhiko Hayashi34, Masahiro Nonaka35, Young‐Soo Park36, Yusuke Kobayashi37, Tadashi Higuchi38, Yosuke Miyairi39, Kazuhisa Yoshifuji40, Noriyoshi Takebe41, Soichi Oya42, Kosuke Nakajo43, Mitsutoshi Nakada44, Yoshiteru Nakano45, Mizuki Kambara46, Koji Adachi47, Kazuhiro Tanaka48, Hideo Nakamura49, Yukihiko Sonoda50, Ryuta Saito51, Takafumi Wataya52, Kazuhiko Kurozumi53, Michael D Taylor54,55,56,57,58,59,60,61,62, Yoshitaka Narita63, Soichiro Shibui64, Hajime Arai65, Hiroaki Sakamoto43,66, Isao Date26, Motoo Nagane32, Ryo Nishikawa14, Yoshiki Arakawa1, Yonehiro Kanemura2,6767 affiliations
- Department of Neurosurgery, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto, Japan
- Department of Biomedical Research and Innovation, Institute for Clinical Research, NHO Osaka National Hospital, Osaka, Japan
- Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan
- Department of Pathology, Kyorin University Faculty of Medicine, Tokyo, Japan
- Department of Pathology, Saitama Medical University, Saitama, Japan
- Department of Pathology, Public Tomioka General Hospital, Gunma, Japan
- Department of Pathology, Osaka City General Hospital, Osaka, Japan
- Department of Central Laboratory and Surgical Pathology, NHO Osaka National Hospital, Osaka, Japan
- Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan
- Department of Neurosurgery, The University of Osaka Graduate School of Medicine, Osaka, Japan
- Department of Neurosurgery, Yukioka Hospital, Osaka, Japan
- Division of Hematology/Oncology, Kanagawa Children's Medical Center, Kanagawa, Japan
- Department of Neurosurgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
- Department of Pediatric Neuro‐Oncology/Neurosurgery, Saitama Medical University International Medical Center, Saitama, Japan
- Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
- Department of Neurosurgery, Gunma University Graduate School of Medicine, Gunma, Japan
- Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Hokkaido, Japan
- Department of Neurosurgery, Tohoku University Graduate School of Medicine, Miyagi, Japan
- Department of Pediatric Hematology and Oncology, Osaka City General Hospital, Osaka, Japan
- Department of Neurosurgery, Osaka City General Hospital, Osaka, Japan
- Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan
- Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan
- Department of Neurosurgery, Shizuoka Children's Hospital, Shizuoka, Japan
- Department of Neurosurgery, Hyogo Prefectural Kobe Children's Hospital, Hyogo, Japan
- Department of Neurosurgery, Fujita Health University School of Medicine, Aichi, Japan
- Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
- Department of Neurosurgery, Chiba Children's Hospital, Chiba, Japan
- Department of Neurological Surgery, Wakayama Medical University School of Medicine, Wakayama, Japan
- Department of Neurosurgery, Keio University School of Medicine, Tokyo, Japan
- Department of Neurosurgery, Fukushima Medical University, Fukushima, Japan
- Department of Neurosurgery, Institute of Medicine, University of Tsukuba, Ibaraki, Japan
- Department of Neurosurgery, Kyorin University School of Medicine, Tokyo, Japan
- Department of Pediatric Neurosurgery, Takatsuki General Hospital, Osaka, Japan
- Department of Neurosurgery, Kanazawa Medical University, Ishikawa, Japan
- Department of Neurosurgery, Kansai Medical University, Osaka, Japan
- Department of Neurosurgery and Children's Medical Center, Nara Medical University, Nara, Japan
- Department of Neurosurgery, Showa Medical University School of Medicine, Tokyo, Japan
- Department of Neurological Surgery, Nippon Medical School, Tokyo, Japan
- Department of Neurosurgery, Nagano Children's Hospital, Nagano, Japan
- Division of Pediatric Neurosurgery, Hokkaido Medical Center for Child Health and Rehabilitation, Hokkaido, Japan
- Department of Neurosurgery, Medical Research Institute Kitano Hospital, PIIF Tazuke‐kofukai, Osaka, Japan
- Department of Neurosurgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan
- Department of Neurosurgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan
- Department of Neurosurgery, Graduate School of Medical Science, Kanazawa University, Ishikawa, Japan
- Department of Neurosurgery, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan
- Department of Neurosurgery, Shimane University Faculty of Medicine, Shimane, Japan
- Department of Neurological Surgery, Nippon Medical School, Musashi‐Kosugi Hospital, Kanagawa, Japan
- Department of Neurosurgery, Kobe University Graduate School of Medicine, Hyogo, Japan
- Department of Neurosurgery, Kurume University School of Medicine, Fukuoka, Japan
- Department of Neurosurgery, Yamagata University Faculty of Medicine, Yamagata, Japan
- Department of Neurosurgery, Nagoya University, Graduate School of Medicine, Aichi, Japan
- Department of Neurosurgery, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan
- Department of Neurosurgery, Hamamatsu University School of Medicine, Shizuoka, Japan
- Texas Children's Cancer and Hematology Center, Houston, Texas, USA
- Department of Pediatrics–Hematology/Oncology, Baylor College of Medicine, Houston, Texas, USA
- Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA
- Department of Neurosurgery, Texas Children's Hospital, Houston, Texas, USA
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA
- The Arthur and Sonia Labatt Brain Tumour Research Centre and the Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada
- Department of Surgery, University of Toronto, Toronto, Ontario, Canada
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
- Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
- Department of Neurosurgery and Neuro‐oncology, National Cancer Center Hospital, Tokyo, Japan
- Department of Neurosurgery, Teikyo University Hospital, Mizonokuchi, Japan
- Department of Neurosurgery, Juntendo University, Tokyo, Japan
- Department of Pediatric Neurosurgery, Osaka City General Hospital, Osaka, Japan
- Department of Neurosurgery, NHO Osaka National Hospital, Osaka, Japan
Abstract
Medulloblastoma (MB) is a biologically and clinically heterogeneous pediatric brain tumor. However, large‐scale molecular subgrouping studies have mainly been conducted in Western populations, and comprehensive data from Asia are limited. To address this gap, we analyzed 242 MB cases collected from 39 institutions through the Japan Pediatric Molecular Neuro‐Oncology Group, performing centralized molecular classification using NanoString‐based gene expression profiling, DNA methylation arrays, and multiplex ligation‐dependent probe amplification (MLPA)‐based copy number profiling, supplemented by targeted sequencing. The subgroup distribution was 16.1% WNT, 24.8% SHH, 17.4% Group 3, and 41.7% Group 4. CTNNB1 mutations and monosomy 6 characterized all WNT cases, whereas MYCN amplification and TP53 mutations were independent adverse markers in SHH MB. Group 3 showed the worst survival, with MYC amplification and metastasis as poor prognostic factors. In Group 4, large cell/
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data, not to its authors' code: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE313522, at NCBI GEO; found in “DATA AVAILABILITY STATEMENT”
Other data links
- ncbi.nlm.nih.gov/
geo , NCBI; found in the text, “Validation analyses using public databases”
Data availability statement
The raw DNA methylation array data (IDAT files) generated in this study were deposited in the NCBI Gene Expression Omnibus (GEO) under the accession number GSE313522 (https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 30 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 71 authors, 5 keywords, 17 MeSH terms, 2 funders, 51 references, 1 integrity notice.
Cite
This paper
Go, K., Katsuma, A., Yoshioka, E., Shofuda, T., Fukuoka, K., Ichimura, K., Matsushita, Y., Mineharu, Y., Makino, Y., Kawauchi, T., Sasaki, A., Hirato, J., Inoue, T., Kodama, Y., Mano, M., Kanematsu, D., Kijima, N., Kagawa, N., Keino, D., . . . Kanemura, Y. (2026). Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/
BibTeX
@article{go2026molecular
author = {Go, Kohichi and Katsuma, Asako and Yoshioka, Ema and Shofuda, Tomoko and Fukuoka, Kohei and Ichimura, Koichi and Matsushita, Yuko and Mineharu, Yohei and Makino, Yasuhide and Kawauchi, Takeshi and Sasaki, Atsushi and Hirato, Junko and Inoue, Takeshi and Kodama, Yoshinori and Mano, Masayuki and Kanematsu, Daisuke and Kijima, Noriyuki and Kagawa, Naoki and Keino, Dai and Mukasa, Akitake and Suzuki, Tomonari and Yoshimoto, Koji and Kuga, Daisuke and Horiguchi, Keishi and Yamaguchi, Shigeru and Kanamori, Masayuki and Yamasaki, Kai and Ishibashi, Kenichi and Akai, Takuya and Yamaoka, Masayoshi and Ishizaki, Ryuji and Kawamura, Atsufumi and Ohba, Shigeo and Ishida, Joji and Ando, Ryo and Fukai, Junya and Miwa, Tomoru and Fujii, Masazumi and Muroi, Ai and Saito, Kuniaki and Harada, Atsuko and Hayashi, Yasuhiko and Nonaka, Masahiro and Park, Young‐Soo and Kobayashi, Yusuke and Higuchi, Tadashi and Miyairi, Yosuke and Yoshifuji, Kazuhisa and Takebe, Noriyoshi and Oya, Soichi and Nakajo, Kosuke and Nakada, Mitsutoshi and Nakano, Yoshiteru and Kambara, Mizuki and Adachi, Koji and Tanaka, Kazuhiro and Nakamura, Hideo and Sonoda, Yukihiko and Saito, Ryuta and Wataya, Takafumi and Kurozumi, Kazuhiko and Taylor, Michael D and Narita, Yoshitaka and Shibui, Soichiro and Arai, Hajime and Sakamoto, Hiroaki and Date, Isao and Nagane, Motoo and Nishikawa, Ryo and Arakawa, Yoshiki and Kanemura, Yonehiro},
title = {{Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/
journal = {Brain pathology (Zurich, Switzerland)},
year = {2026},
month = mar,
volume = {36},
number = {5},
pages = {e70092},
publisher = {Wiley},
issn = {1015-6305},
doi = {10.1111/
url = {https://
pmid = {41808532},
pmcid = {PMC13429296}
}
RIS
TY - JOUR
AU - Go, Kohichi
AU - Katsuma, Asako
AU - Yoshioka, Ema
AU - Shofuda, Tomoko
AU - Fukuoka, Kohei
AU - Ichimura, Koichi
AU - Matsushita, Yuko
AU - Mineharu, Yohei
AU - Makino, Yasuhide
AU - Kawauchi, Takeshi
AU - Sasaki, Atsushi
AU - Hirato, Junko
AU - Inoue, Takeshi
AU - Kodama, Yoshinori
AU - Mano, Masayuki
AU - Kanematsu, Daisuke
AU - Kijima, Noriyuki
AU - Kagawa, Naoki
AU - Keino, Dai
AU - Mukasa, Akitake
AU - Suzuki, Tomonari
AU - Yoshimoto, Koji
AU - Kuga, Daisuke
AU - Horiguchi, Keishi
AU - Yamaguchi, Shigeru
AU - Kanamori, Masayuki
AU - Yamasaki, Kai
AU - Ishibashi, Kenichi
AU - Akai, Takuya
AU - Yamaoka, Masayoshi
AU - Ishizaki, Ryuji
AU - Kawamura, Atsufumi
AU - Ohba, Shigeo
AU - Ishida, Joji
AU - Ando, Ryo
AU - Fukai, Junya
AU - Miwa, Tomoru
AU - Fujii, Masazumi
AU - Muroi, Ai
AU - Saito, Kuniaki
AU - Harada, Atsuko
AU - Hayashi, Yasuhiko
AU - Nonaka, Masahiro
AU - Park, Young‐Soo
AU - Kobayashi, Yusuke
AU - Higuchi, Tadashi
AU - Miyairi, Yosuke
AU - Yoshifuji, Kazuhisa
AU - Takebe, Noriyoshi
AU - Oya, Soichi
AU - Nakajo, Kosuke
AU - Nakada, Mitsutoshi
AU - Nakano, Yoshiteru
AU - Kambara, Mizuki
AU - Adachi, Koji
AU - Tanaka, Kazuhiro
AU - Nakamura, Hideo
AU - Sonoda, Yukihiko
AU - Saito, Ryuta
AU - Wataya, Takafumi
AU - Kurozumi, Kazuhiko
AU - Taylor, Michael D
AU - Narita, Yoshitaka
AU - Shibui, Soichiro
AU - Arai, Hajime
AU - Sakamoto, Hiroaki
AU - Date, Isao
AU - Nagane, Motoo
AU - Nishikawa, Ryo
AU - Arakawa, Yoshiki
AU - Kanemura, Yonehiro
TI - Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/
T2 - Brain pathology (Zurich, Switzerland)
J2 - Brain Pathol
PY - 2026
DA - 2026/
VL - 36
IS - 5
SP - e70092
SN - 1015-6305
PB - Wiley
DO - 10.1111/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1111/
"type": "article-journal",
"title": "Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/
"container-title": "Brain pathology (Zurich, Switzerland)",
"author": [
{
"family": "Go",
"given": "Kohichi"
},
{
"family": "Katsuma",
"given": "Asako"
},
{
"family": "Yoshioka",
"given": "Ema"
},
{
"family": "Shofuda",
"given": "Tomoko"
},
{
"family": "Fukuoka",
"given": "Kohei"
},
{
"family": "Ichimura",
"given": "Koichi"
},
{
"family": "Matsushita",
"given": "Yuko"
},
{
"family": "Mineharu",
"given": "Yohei"
},
{
"family": "Makino",
"given": "Yasuhide"
},
{
"family": "Kawauchi",
"given": "Takeshi"
},
{
"family": "Sasaki",
"given": "Atsushi"
},
{
"family": "Hirato",
"given": "Junko"
},
{
"family": "Inoue",
"given": "Takeshi"
},
{
"family": "Kodama",
"given": "Yoshinori"
},
{
"family": "Mano",
"given": "Masayuki"
},
{
"family": "Kanematsu",
"given": "Daisuke"
},
{
"family": "Kijima",
"given": "Noriyuki"
},
{
"family": "Kagawa",
"given": "Naoki"
},
{
"family": "Keino",
"given": "Dai"
},
{
"family": "Mukasa",
"given": "Akitake"
},
{
"family": "Suzuki",
"given": "Tomonari"
},
{
"family": "Yoshimoto",
"given": "Koji"
},
{
"family": "Kuga",
"given": "Daisuke"
},
{
"family": "Horiguchi",
"given": "Keishi"
},
{
"family": "Yamaguchi",
"given": "Shigeru"
},
{
"family": "Kanamori",
"given": "Masayuki"
},
{
"family": "Yamasaki",
"given": "Kai"
},
{
"family": "Ishibashi",
"given": "Kenichi"
},
{
"family": "Akai",
"given": "Takuya"
},
{
"family": "Yamaoka",
"given": "Masayoshi"
},
{
"family": "Ishizaki",
"given": "Ryuji"
},
{
"family": "Kawamura",
"given": "Atsufumi"
},
{
"family": "Ohba",
"given": "Shigeo"
},
{
"family": "Ishida",
"given": "Joji"
},
{
"family": "Ando",
"given": "Ryo"
},
{
"family": "Fukai",
"given": "Junya"
},
{
"family": "Miwa",
"given": "Tomoru"
},
{
"family": "Fujii",
"given": "Masazumi"
},
{
"family": "Muroi",
"given": "Ai"
},
{
"family": "Saito",
"given": "Kuniaki"
},
{
"family": "Harada",
"given": "Atsuko"
},
{
"family": "Hayashi",
"given": "Yasuhiko"
},
{
"family": "Nonaka",
"given": "Masahiro"
},
{
"family": "Park",
"given": "Young‐Soo"
},
{
"family": "Kobayashi",
"given": "Yusuke"
},
{
"family": "Higuchi",
"given": "Tadashi"
},
{
"family": "Miyairi",
"given": "Yosuke"
},
{
"family": "Yoshifuji",
"given": "Kazuhisa"
},
{
"family": "Takebe",
"given": "Noriyoshi"
},
{
"family": "Oya",
"given": "Soichi"
},
{
"family": "Nakajo",
"given": "Kosuke"
},
{
"family": "Nakada",
"given": "Mitsutoshi"
},
{
"family": "Nakano",
"given": "Yoshiteru"
},
{
"family": "Kambara",
"given": "Mizuki"
},
{
"family": "Adachi",
"given": "Koji"
},
{
"family": "Tanaka",
"given": "Kazuhiro"
},
{
"family": "Nakamura",
"given": "Hideo"
},
{
"family": "Sonoda",
"given": "Yukihiko"
},
{
"family": "Saito",
"given": "Ryuta"
},
{
"family": "Wataya",
"given": "Takafumi"
},
{
"family": "Kurozumi",
"given": "Kazuhiko"
},
{
"family": "Taylor",
"given": "Michael D"
},
{
"family": "Narita",
"given": "Yoshitaka"
},
{
"family": "Shibui",
"given": "Soichiro"
},
{
"family": "Arai",
"given": "Hajime"
},
{
"family": "Sakamoto",
"given": "Hiroaki"
},
{
"family": "Date",
"given": "Isao"
},
{
"family": "Nagane",
"given": "Motoo"
},
{
"family": "Nishikawa",
"given": "Ryo"
},
{
"family": "Arakawa",
"given": "Yoshiki"
},
{
"family": "Kanemura",
"given": "Yonehiro"
}
],
"container-title-short":
"volume": "36",
"issue": "5",
"page": "e70092",
"DOI": "10.1111/
"PMID": "41808532",
"PMCID": "PMC13429296",
"ISSN": "1015-6305",
"publisher": "Wiley",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
3,
11
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1186/s40478-026-02302-1
- Ovarian central nervous system-type tumors: integrated neuropathological and methylation-based classification reveals site-related features.Journal: Acta neuropathologica communicationsIn common: genetics / omics, other condition, 5 references
- [2] doi:10.1038/s12276-026-01732-0
- Comprehensive proteogenomic characterization reveals clinically relevant molecular subtypes associated with medulloblastoma progression.Journal: Experimental & molecular medicineIn common: genetics / omics, other condition, 4 references
- [3] doi:10.1038/s43856-026-01454-4
- An interpretable machine learning model for predicting prognosis of medulloblastoma integrating genetic and clinical features.Journal: Communications medicineIn common: other condition, 4 references
- [4] doi:10.1007/s12017-026-08935-8
- Subgroup-Specific Associations of GRIA Genes Encoding AMPA Glutamate Receptor Subunits with Patient Survival in Medulloblastoma.Journal: Neuromolecular medicineIn common: genetics / omics, other condition, 3 references
- [5] doi:10.1038/s41467-026-74782-7
- Anti-PD-1 plus anti-CTLA-4 blockade overcomes immune exclusion in NSCLC brain metastases by enhancing CD8&
lt;sup& gt;+& lt;/ sup& gt; T cell responses and promoting tertiary lymphoid structure formation. Journal: Nature communicationsIn common: other condition, author Yohei Mineharu - [6] doi:10.7150/ijbs.116040
- Elucidating Tumorigenesis Mechanisms and Assessing Immunotherapeutic Efficacy in Patient-Derived Medulloblastoma Organoid Models.Journal: International journal of biological sciencesIn common: genetics / omics, other condition, 3 references
- [7] doi:10.1186/s40478-026-02382-z
- Methylation profiling and alternative classification approaches in a glioma-enriched FFPE stereotaxic biopsy cohort.Journal: Acta neuropathologica communicationsIn common: genetics / omics, other condition, 3 references
- [8] doi:10.1186/s40478-026-02269-z
- Histological grade 2 and non-contrast-enhancing phenotype provide prognostic information complementary to DNA methylation classification in TERTp-mutant molecular glioblastomas.Journal: Acta neuropathologica communicationsIn common: genetics / omics, other condition, 3 references
- [9] doi:10.1038/s41586-026-10631-3 [code]
- A prognostic human brain network for diffuse midline glioma.Journal: NatureIn common: other condition, 3 references
- [10] doi:10.3390/cells15050474
- Longitudinal Detection of Tumor-Specific Peptides in Cerebrospinal Fluid for Pediatric Brain Tumor Surveillance.Journal: CellsIn common: genetics / omics, other condition, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
